Aura Biosciences (AURA) Stock Forecast — 2-Week Outlook

StockMap's current 2-week read on Aura Biosciences (AURA) is Moderate Underperform.

The composite score behind that read is -0.21, weighing +0.12 of bullish evidence against -0.28 bearish.

Aura Biosciences last closed at $6.22, +2.13% on the session.

Against the IVW growth benchmark the position is +1.21% over the forecast window.

The read is built from 12 underlying insights — 3 bullish and 9 bearish.

Agreement across those insights is 75%.

16 graded predictions for AURA so far. We publish our accuracy across thousands of stocks in the open, misses included — no per-stock hit rate is claimed on a small sample.

On the fundamentals StockMap ranks Aura Biosciences in the 14th percentile on return on equity, where 100 is best.

Aura Biosciences is classified under Health Care / Biotechnology, with a market capitalisation of $631.56M.

StockMap tracks Aura Biosciences as the 154th largest of the 344 companies it covers in the Biotechnology industry, part of the Health Care sector.

Across that group the current two-week reads are 180 Moderate Underperform, 152 Neutral, 11 Strong Underperform and 1 Moderate Outperform.

On that composite Aura Biosciences ranks 156th of 344 in the group, against a group median of -0.21.